Viewing Study NCT00003693

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2026-03-19 @ 5:30 PM
Study NCT ID: NCT00003693
Status: COMPLETED
Last Update Posted: 2018-10-25
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult acute myeloid leukemia View
None recurrent adult acute lymphoblastic leukemia View
None relapsing chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None refractory anemia with excess blasts View
None refractory anemia with excess blasts in transformation View
None chronic myelomonocytic leukemia View
None previously treated myelodysplastic syndromes View
None childhood myelodysplastic syndromes View